KUMIAI CHEMICAL INDUSTRY CO.,LTD. FY2026 Q3 Earnings Report

Financial Highlights

• Net Sales: ¥141.41B
• Operating Income: ¥7.63B
• Net Income: ¥5.58B
• EPS: ¥47.53

Income Statement

Balance Sheet

Profitability Ratios

Year-over-Year Comparison

Share Information

Dividend Information

Segment Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was mixed: revenue expanded, but the core agricultural chemicals business experienced substantial operating-profit pressure and bottom-line earnings declined. Cumulative revenue rose 5.1% year on year to ¥141.4bn. Operating income fell 26.7% to ¥7.6bn, reducing the operating margin to 5.4% from 7.7% in the prior-year period, a 230bp contraction. Gross margin declined to 18.0% from 20.7%, a 270bp deterioration, indicating that cost-of-sales growth outpaced sales growth. SG&A expenses increased only 2.6% to ¥17.9bn, slower than revenue, and the SG&A-to-sales ratio declined by roughly 31bp; consequently, the earnings pressure was principally at the gross-profit level rather than from overhead deleveraging. Agricultural Chemicals and Agriculture Related, the core business with 79.1% of revenue, grew sales 3.5% to ¥111.9bn but segment operating income declined 32.0% to ¥6.8bn. Chemicals was the principal offset, with revenue rising 19.5% to ¥22.5bn and operating income increasing 31.0% to ¥1.9bn. The Chemicals segment's 8.3% margin exceeded the 6.1% margin in Agricultural Chemicals, although its smaller scale limits its ability to fully offset the core-business decline. Ordinary income nevertheless increased 5.5% to ¥12.2bn because non-operating income increased to ¥5.2bn. Equity-method earnings increased ¥11.6bn year on year to ¥36.7bn, while foreign-exchange gains of ¥9.6bn replaced the prior-year foreign-exchange loss of ¥15.6bn. Thus, the improvement in ordinary income was driven primarily by affiliate earnings and currency effects rather than by consolidated operating profitability. Profit attributable to owners fell 36.7% to ¥5.7bn, reflecting a 47.7% effective tax rate and net extraordinary losses of ¥15.4bn, including ¥5.1bn of impairment. Annualized ROE was 4.9%, below levels generally associated with attractive capital efficiency, with the low 4.0% net margin the principal constraint. The balance sheet remains conservatively capitalized, with a 225.0% current ratio, 0.56x debt-to-equity ratio, and 61.5% capital adequacy ratio. Cash increased and inventories declined materially year on year, but working-capital intensity remains high, with quality alerts showing 81-day receivables, 104-172-day inventory metrics, and a 199-day cash conversion cycle. Management revised its full-year forecast: the Q3 cumulative operating income of ¥7.6bn already exceeds the full-year ¥2.7bn forecast, whereas sales progress is 80.8% against a standard 75% Q3 pace. The outlook therefore embeds a sharply loss-making or highly seasonal Q4 at the operating level, making the timing of agricultural-chemical shipments, pricing, inventories, and affiliate income central to the year-end outcome.

Profitability Analysis

Annualized DuPont ROE is 4.9%, decomposed into a 4.0% net profit margin, 0.783x asset turnover, and 1.56x financial leverage. The low net margin is the largest limiting factor: while leverage is moderate and asset turnover is reasonable for the reported asset base, neither offsets weak after-tax profitability. Gross margin fell 270bp year on year to 18.0%, and operating margin declined 230bp to 5.4%; this confirms that gross-profit compression was the main driver of the ¥2.8bn operating-income decline. SG&A grew 2.6%, below 5.1% revenue growth, so overhead discipline partially mitigated rather than caused the margin compression. The five-factor analysis also highlights an unusually weak tax burden of 0.537, equivalent to a 47.7% effective tax rate. Interest burden exceeds 1.0 because non-operating income, particularly equity-method earnings and FX gains, more than offsets net interest costs; this should not be interpreted as evidence that the operating business has structurally superior margins. Interest coverage of 15.5x remains strong. The Agricultural Chemicals segment is the core earnings issue: its 6.1% segment margin and 32.0% profit decline contrast with Chemicals' 8.3% margin and 31.0% profit growth. Segment-level profit totaled ¥9.3bn before ¥1.7bn of unallocated corporate costs, versus ¥12.0bn before ¥1.6bn of such costs in the prior year. The ¥5.1bn impairment and net extraordinary losses further reduced the conversion of ordinary income into net income. The current profitability profile is therefore dependent on recovery in core segment gross margin and on the repeatability of affiliate and FX contributions.

Growth Assessment

Revenue growth of 5.1% was supported by Chemicals, which expanded 19.5%, and by a 3.5% increase in Agricultural Chemicals and Agriculture Related sales. The core business remains highly concentrated, contributing 79.1% of consolidated revenue, so its operating-profit decline has disproportionate relevance for group earnings. Other businesses posted a 6.7% revenue decline to ¥7.0bn but a 13.7% increase in operating income to ¥0.6bn. Consolidated revenue has reached 80.8% of the revised full-year ¥175.0bn forecast, 5.8 percentage points ahead of the standard 75% Q3 progress rate. Ordinary income of ¥12.2bn is 143.6% of the ¥8.5bn full-year forecast, and profit attributable to owners of ¥5.7bn is 143.1% of the ¥4.0bn forecast. Operating income of ¥7.6bn is 282.5% of the ¥2.7bn full-year forecast. These progress rates indicate that the revised forecast assumes pronounced Q4 cost, seasonal, pricing, or inventory-related pressure, despite sales progress being ahead of the normal run rate. The increase in equity-method earnings to ¥36.7bn and the swing to ¥9.6bn of FX gains supported ordinary income, but these items are less directly linked to the operating recovery of the core manufacturing and agricultural-chemicals activities. Sustainability of earnings growth therefore depends more on restoring agricultural-chemical gross margins than on extending non-operating gains.

Financial Health

Liquidity is strong on reported balance-sheet measures: the current ratio is 225.0%, the quick ratio is 157.1%, and working capital is ¥81.3bn. Current assets of ¥146.3bn comfortably exceed current liabilities of ¥65.0bn, including ¥34.3bn of short-term loans. Interest-bearing debt totals ¥43.8bn, equal to 0.56x equity, while debt-to-capital is 22.1%; both indicate conservative aggregate leverage. Interest coverage of 15.5x provides substantial protection against current interest costs. The principal refinancing consideration is debt maturity concentration: 78.3% of interest-bearing debt is short-term, and cash of ¥29.4bn covers 0.86x short-term loans. This short-term debt ratio is elevated versus the 40% alert threshold, creating a need for regular refinancing access even though current assets and liquidity provide considerable support. Long-term loans declined ¥4.8bn, or 33.8%, year on year to ¥9.5bn, while short-term loans declined ¥2.4bn to ¥34.3bn. Cash and deposits increased ¥7.4bn, or 33.7%, to ¥29.4bn, improving near-term funding flexibility. Total liabilities fell ¥11.0bn while total equity increased ¥3.6bn year on year, lifting capital adequacy to 61.5% from 58.2%. Goodwill is only ¥1.1bn, or 0.7% of equity, and intangible assets are 0.9% of total assets, leaving little balance-sheet dependence on acquisition values. Asset-retirement obligations of ¥0.2bn are immaterial relative to total liabilities.

Notable B/S Changes

Cash and deposits: +¥7.4bn (+33.7%) to ¥29.4bn - improves immediate liquidity and partly supports the short-term debt funding requirement. Inventories: -¥15.7bn (-26.2%) to ¥44.1bn - favorable inventory release, although inventory remains material at 18.3% of total assets and working-capital alerts remain elevated. Long-term loans: -¥4.8bn (-33.8%) to ¥9.5bn - lowers long-term leverage but leaves the debt structure more reliant on ¥34.3bn of short-term loans. Investment securities: +¥2.8bn (+7.1%) to ¥41.4bn, representing 17.2% of total assets - the investment portfolio is significant and contributes to exposure to market-value movements and affiliate-related earnings.

Cash Flow Quality

Working-capital efficiency is the principal cash-conversion concern. Quality alerts identify annualized receivable days of 81, above the 60-day warning level, which increases the amount of funding tied up in customer collections. Inventory alerts show annualized inventory-day measures of 104 days and 172 days, both above relevant warning thresholds and consistent with a long production and distribution cycle. The 199-day annualized cash conversion cycle is well above the 120-day warning level, indicating that profits and sales require substantial working-capital funding before conversion to cash. The year-on-year ¥15.7bn, or 26.2%, reduction in inventories to ¥44.1bn is a favorable balance-sheet development and may ease funding requirements if maintained. However, inventories still represent 18.3% of total assets and receivables represent 17.4%, making collection discipline, demand planning, and inventory turns material determinants of cash generation. For a chemical manufacturer, prolonged inventory holding also raises exposure to demand shifts, product obsolescence, carrying costs, and potential valuation losses. The impairment loss of ¥5.1bn and total extraordinary losses of ¥18.0bn further demonstrate that reported earnings can be affected by non-recurring charges. Equity-method earnings of ¥36.7bn materially supported ordinary income, so the cash availability of affiliate returns and dividends remains relevant to group-level earnings conversion.

Dividend Sustainability

The interim dividend is ¥10.00 per share. The calculated payout ratio presented for the interim distribution is 23.3%, indicating moderate use of current-period earnings for that payment. The revised full-year dividend forecast is ¥24.00 per share against forecast EPS of ¥33.20, implying a forecast dividend payout ratio of approximately 72.3%. This is above the 60% sustainability benchmark but remains below 100%, provided the revised earnings forecast is achieved. The forecast DPS also implies a ¥14.00 per-share year-end payment after the ¥10.00 interim dividend. Retained earnings of ¥113.2bn and total equity of ¥154.7bn provide a substantial capital buffer for the planned shareholder distribution. Dividend resilience should nevertheless be evaluated against the high working-capital intensity, the 78.3% short-term debt mix, and the possibility that Q4 operating profitability is materially weaker than the Q3 cumulative result implies. The sustainability of the ¥24.00 annual dividend will depend principally on completion of the agricultural-chemical selling season, inventory monetization, and the realization of forecast earnings.

Risk Assessment

Business risks include High core-business concentration: Agricultural Chemicals and Agriculture Related accounts for 79.1% of revenue, and its operating income fell 32.0% year on year. Agricultural demand, weather conditions, crop cycles, regulatory approvals, product pricing, and competitive launches can therefore materially affect group results., Gross-margin pressure: the 270bp decline in gross margin to 18.0% was the primary driver of lower operating income. Input-cost inflation, production utilization, pricing discipline, and product mix are key risks for a chemical manufacturer., Working-capital and inventory risk: annualized DSO of 81 days, annualized DIO alerts of 104 days and 172 days, and a 199-day cash conversion cycle indicate slow conversion of sales into cash. Extended inventory holding can increase obsolescence, demand-forecasting, and inventory-valuation risk., Affiliate and FX dependence: equity-method earnings of ¥36.7bn and FX gains of ¥9.6bn supported ordinary income. Volatility in investee performance, exchange rates, and the timing of affiliate earnings could cause ordinary income to diverge from operating trends., Environmental and compliance exposure: chemical operations remain exposed to product registration requirements, environmental regulations, remediation obligations, and safety incidents; the reported asset-retirement obligation is small, but compliance failures can have outsized operational and reputational effects..

Financial risks include Refinancing risk is elevated by the 78.3% short-term debt ratio. Cash covers 0.86x short-term loans, requiring continued access to banking facilities or working-capital liquidity despite strong current and quick ratios., Low capital efficiency: annualized ROE is 4.9% and the quality alert identifies ROIC of 3.1%, below the 5% warning threshold. Persistently low returns could constrain valuation support and capital-allocation flexibility., High tax burden: the 47.7% effective tax rate produces a tax burden of 0.537, below the 0.60 warning level, materially reducing the conversion of pre-tax profit into net income., Non-recurring charges: ¥5.1bn of impairment and ¥18.0bn of extraordinary losses depressed earnings and create risk of further asset-value reassessments if market conditions weaken..

Key concerns include Highest impact: whether agricultural-chemical gross margin and segment earnings recover after the 32.0% operating-profit decline., High likelihood and impact: whether inventory and receivable days normalize sufficiently to reduce the 199-day cash conversion cycle., High impact: the revised full-year forecast implies a sharply weaker Q4 operating outcome despite Q3 operating income already exceeding the annual forecast., Moderate-to-high impact: sustainability of ordinary income given the material contributions from equity-method earnings and FX gains., Moderate impact: maintenance of the ¥24.00 full-year dividend under a 72.3% forecast payout ratio while short-term debt remains the dominant funding source..

Investment Implications

Key takeaways include Revenue growth has not translated into operating earnings growth: sales rose 5.1%, while operating income fell 26.7% and operating margin contracted 230bp to 5.4%., Chemicals is growing profitably, but the larger Agricultural Chemicals and Agriculture Related business remains the decisive earnings driver., Ordinary income growth was supported by ¥36.7bn of equity-method earnings and ¥9.6bn of FX gains, reducing the visibility of underlying operating-profit momentum., The balance sheet is strong in aggregate, with 61.5% capital adequacy, 0.56x debt-to-equity, and a 225.0% current ratio, although funding maturity is short-term weighted., The revised annual forecast and the ¥24.00 DPS forecast require close scrutiny because cumulative Q3 profit measures already exceed their full-year targets..

Metrics to watch include Agricultural Chemicals and Agriculture Related segment revenue, margin, and operating income, Consolidated gross margin and operating margin, Inventory balance, inventory days, receivable days, and cash conversion cycle, Short-term loan balance, cash-to-short-term-debt coverage, and refinancing terms, Equity-method earnings and foreign-exchange gains or losses, Impairment charges and the effective tax rate, Q4 operating-income trajectory relative to the revised ¥2.7bn full-year forecast, Achievement of the ¥24.00 full-year dividend forecast.

Regarding relative positioning, The company combines a comparatively strong capital base and low goodwill exposure with below-benchmark return metrics, a low 18.0% gross margin, and a working-capital cycle that is long for efficient manufacturing operations. Its financial risk is moderated by low aggregate leverage and strong liquidity ratios, but its earnings profile is less defensive than those ratios alone suggest because operating profit is concentrated in agricultural chemicals and ordinary income is materially influenced by affiliates and FX.